IsoSol

Manufacturer
Vedco, Inc. | Piramal Pharma Limited
Effective date
2023-02-02
Label type
Prescription Animal Drug Label
Version
7
Source
full-release
Hydrated at
2026-06-01 02:41:52

Label at a glance#

ProductIsoSol
Active ingredientISOFLURANE
Label structure13 sections

Label contents#

Full prescribing information#

CAUTION

SPL UNCLASSIFIED SECTION

Federal law restricts this drug to use by or on the order of a licensed veterinarian.



DESCRIPTION

DESCRIPTION SECTION

Isoflurane, USP is a nonflammable, nonexplosive general inhalation anesthetic agent. Its chemical name is l-chloro-2,2,2-trifluoroethyl difluoromethyl ether, and its structural formula is:


iso-structureiso-structure



Each mL contains 99.9% isoflurane.


Some physical constants are:


Molecular weight
 
184.5
Boiling point at 760 mm Hg
 
48.5° C (uncorr.)
Refractive index n 20
                                          D
 
1.2990-1.3005
Specific gravity 25°/25° C
 
1.496
Vapor pressure in mm Hg**
20° C
238
 
25° C
295
 
30° C
367
 
35° C
450

**Equation for vapor pressure calculation:

log10 Pvap = A + B             

                         T                              where:        A = 8.056

                                                                            B = -1664.58

                                                                            T = °C + 273.16 (Kelvin)


Partition coefficients at 37° C:
 
 
 
Water/gas
0.61
 
Blood/gas
1.43
 
Oil/gas
90.8

Partition coefficients at 25° C - rubber and plastic
 
Conductive rubber/gas
62.0
 
Butyl rubber/gas
75.0
 
Polyvinyl chloride/gas
110.0
 
Polyethylene/gas
~2.0
 
Polyurethane/gas
~1.4
 
Polyolefin/gas
~1.1
 
Butyl acetate/gas
~2.5
Purity by gas chromatography
>99.9%
Lower limit of flammability in oxygen or
nitrous oxide at 9 joules/sec. and 23° C
None
Lower limit of flammability in oxygen or nitrous oxide at 900 joules/sec. and 23° C
Greater than useful concentration in anesthesia.

MAC (Minimum Alveolar Concentration) is 1.31% in horses1 and 1.28% in dogs.6

Isoflurane is a clear, colorless, stable liquid containing no additives or chemical stabilizers. Isoflurane has a mildly pungent, musty, ethereal odor. Samples stored in indirect sunlight in clear, colorless glass for five years, as well as samples directly exposed for 30 hours to a 2 amp, 115 volt, 60 cycle long wave U.V. light were unchanged in composition as determined by gas chromatography. Isoflurane in one normal sodium methoxide-methanol solution, a strong base, for over six months consumed essentially no alkali, indicative of strong base stability. Isoflurane does not decompose in the presence of soda lime (at normal operating temperatures), and does not attack aluminum, tin, brass, iron or copper.

  

CLINICAL PHARMACOLOGY

CLINICAL PHARMACOLOGY SECTION

Isoflurane, USP is an inhalation anesthetic. Induction and recovery from anesthesia with isoflurane are rapid.2,5 The level of anesthesia may be changed rapidly with isoflurane. Isoflurane is a profound respiratory depressant. RESPIRATION MUST BE MONITORED CLOSELY IN THE HORSE AND DOG AND SUPPORTED WHEN NECESSARY. As anesthetic dose is increased, both tidal volume and respiratory rate decrease.3,6 This depression is partially reversed by surgical stimulation, even at deeper levels of anesthesia.

Blood pressure decreases with induction of anesthesia but returns toward normal with surgical stimulation. Progressive increases in depth of anesthesia produce corresponding decreases in blood pressure; however, heart rhythm is stable and cardiac output is maintained with controlled ventilation and normal PaCO2 despite increasing depth of anesthesia. The hypercapnia which attends spontaneous ventilation during isoflurane anesthesia increases heart rate and raises cardiac output above levels observed with controlled ventilation.3 Isoflurane does not sensitize the myocardium to exogenously administered epinephrine in the dog.

Muscle relaxation may be adequate for intra-abdominal operations at normal levels of anesthesia. However, if muscle relaxants are used to achieve greater relaxation, it should be noted that: ALL COMMONLY USED MUSCLE RELAXANTS ARE MARKEDLY POTENTIATED WITH ISOFLURANE, THE EFFECT BEING MOST PROFOUND WITH THE NONDEPOLARIZING TYPE. Neostigmine reverses the effect of nondepolarizing muscle relaxants in the presence of isoflurane but does not reverse the direct neuromuscular depression of isoflurane.

INDICATIONS

INDICATIONS & USAGE SECTION

Isoflurane, USP is used for induction and maintenance of general anesthesia in horses and dogs.

CONTRAINDICATIONS

CONTRAINDICATIONS SECTION

Isoflurane, USP is contraindicated in horses and dogs with known sensitivity to isoflurane or to other halogenated agents.

WARNINGS

WARNINGS SECTION

Increasing depth of anesthesia with Isoflurane,USP may increase hypotension and respiratory depression. The electroencephalographic pattern associated with deep anesthesia is characterized by burst suppression, spiking, and isoelectric periods.4

Since levels of anesthesia may be altered easily and rapidly, only vaporizers producing predictable percentage concentrations of isoflurane should be used. (See DOSAGE AND ADMINISTRATION).

The action of nondepolarizing relaxants is augmented by isoflurane. Less than the usual amounts of these drugs should be used. If the usual amounts of nondepolarizing relaxants are given, the time for recovery from myoneural blockade will be longer in the presence of isoflurane than in the presence of other commonly used anesthetics.

Not for use in horses intended for food.

Keep out of reach of children.

PRECAUTIONS

PRECAUTIONS SECTION

Isoflurane, USP like other inhalational anesthetics, can react with desiccated carbon dioxide (CO2) absorbents to produce carbon monoxide which may result in elevated carboxyhemoglobin levels in some patients. Case reports suggest that barium hydroxide lime and soda lime become desiccated when fresh gases are passed through the CO2 absorber canister at high flow rates over many hours or days. When a clinician suspects that CO2 absorbent may be desiccated, it should be replaced before the administration of Isoflurane,USP.

Usage in Pregnancy:

PREGNANCY SECTION

Reproduction studies have been performed in mice and rats with no evidence of fetal malformation attributable to isoflurane. Adequate data concerning the safe use of isoflurane in pregnant and breeding horses and dogs have not been obtained.

ADVERSE REACTIONS

ADVERSE REACTIONS SECTION

Hypotension, respiratory depression, and arrhythmias have been reported.

OVERDOSAGE

OVERDOSAGE SECTION

In the event of overdosage, or what may appear to be overdosage, the following action should be taken:

Stop drug administration, establish that the airway is clear and initiate assisted or controlled ventilation with pure oxygen as circumstances dictate.

DOSAGE & ADMINISTRATION

DOSAGE & ADMINISTRATION SECTION

Caution

Spl Unclassified Section

Operating rooms should be provided with adequate ventilation to prevent the accumulation of anesthetic vapors.

Premedication

Spl Unclassified Section

Premedication: A premedication regimen, which may be employed depending upon the patient status, to avert excitement during induction, might include an anticholinergic, a tranquilizer, a muscle relaxant, and a short-acting barbiturate.

Inspired Concentration

Spl Unclassified Section

Inspired Concentration: The delivered concentration of Isoflurane, USP should be known. Isoflurane may be vaporized using a flow-through vaporizer specifically calibrated for isoflurane. Vaporizers delivering a saturated vapor which is then diluted (e.g. Vernitrol®  vaporizer) also may be used. The delivered concentration from such a vaporizer may be calculated using the formula:

% Isoflurane = 100 PvFv
                         FT (PA – Pv)

where:             PA = Pressure of atmosphere 
                         PV = Vapor pressure of isoflurane 
                         FV = Flow of gas through vaporizer (mL/min) 
                         FT = Total gas flow (mL/min)

Isoflurane contains no stabilizer. Nothing in the drug product alters calibration or operation of these vaporizers.

Induction

Spl Unclassified Section

Horses: Inspired concentrations of 3.0% to 5.0% isoflurane alone with oxygen following a barbiturate anesthetic induction are usually employed to induce surgical anesthesia in the horse.

Dogs: Inspired concentrations of 2.0% to 2.5% isoflurane alone with oxygen following a barbiturate anesthetic induction are usually employed to induce surgical anesthesia in the dog.

These concentrations can be expected to produce surgical anesthesia in 5 to 10 minutes.

Maintenance: The concentration of vapor necessary to maintain anesthesia is much less than that required to induce it.

Horses: Surgical levels of anesthesia in the horse may be sustained with a 1.5% to 1.8% concentration of isoflurane in oxygen.

Dogs: Surgical levels of anesthesia in the dog may be sustained with a 1.5% to 1.8% concentration of isoflurane in oxygen.

The level of blood pressure during maintenance is an inverse function of isoflurane concentration in the absence of other complicating problems. Excessive decreases, unless related to hypovolemia, may be due to depth of anesthesia and in such instances may be corrected by lightening the level of anesthesia.

Recovery from isoflurane anesthesia is typically uneventful.2

HOW SUPPLIED

HOW SUPPLIED SECTION

Isoflurane, USP is packaged in 100 mL (NDC 50989-150-12) and 250 mL (NDC 50989-150-15) amber-colored bottles.

Storage

Spl Unclassified Section

Store at room temperature 20º to 25ºC (68º to 77ºF); excursions permitted to 15° to 30°C (59° to 86°F) [See USP Controlled Room Temperature].

REFERENCES

REFERENCES SECTION

1. Steffey EP, Howland D Jr, Giri S, Eger E1 II.
Enflurane, Halothane and Isoflurane Potence in Horses. AM J Vet Res. 38(7): 1037-1039, 1977.
2.Auer JA, Garner HE, Amend JF, Hutcheson DP, Salem CA.Recovery from Anesthesia in Ponies: A Comparative Study of the Effects of Isoflurane, Enflurane, Methoxyflurane and Halothane. Equine Vet J.10 (1): 18-231978.
3.Steffey Ep, Howland D Jr.: Comparison of Circulatory and Respiratory Effects of Isoflurane and Halothane Anesthesia in Horses. Am J Vet Res.41(5): 821-825, 1980.
4.Auer JA, Amend JF, Garner HE, Hutcheson DP, Salem CA. Electroencephalographic Responses During Volatile Anesthesia in DOmestic Ponies: A Comparative Study of Isoflurane, Enflurane, Methoxyflurane, and Halothane. Equine Practice 3: 130-134, 1979.
5. Klide A.M. Cardiopulmonary Effects of Enflurane and Isoflurane in the Dog. AmJ.Vet.Res: Vol.37, No2: 127-131, 1976.
6. Steffey EP, Howland D: Isoflurane Potency in the Dog and Cat. Am J Vet Res., Vol.38, No 11: 1833-1836, 1977

Issue Date: January 2023


To report suspected adverse drug events, for technical assistance or to obtain a copy of the Safety Data Sheet, contact VEDCO Inc. at 888-708-3326. For additional information about adverse drug experience reporting for animal drugs, contact FDA at 1-888-FDA-VETS, or online at www.fda.gov/reportanimalae.

Approved by FDA under ANADA # 200-237

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL-100mL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 50989-150-12

IsoSolTM

Isoflurane,USP

100mL

For Veterinary Use in Horse and Dogs

isosol-100ml-labelisosol-100ml-label

 

 

PRINCIPAL DISPLAY PANEL-250mL

Spl Unclassified Section

NDC 50989-150-15

IsoSolTM

Isoflurane,USP

250mL

For Veterinary Use in Horse and Dogs

 

isosol-250ml-labelisosol-250ml-label

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
542347isoflurane 99.9 % Inhalation SolutionPSN7
1549863IsoSol 99.9 % Inhalation SolutionPSN7
1549863isoflurane 999 MG/ML Inhalation Solution [IsoSol]SBD7
542347isoflurane 999 MG/ML Inhalation SolutionSCD7
542347isoflurane 99.9 % Inhalation SolutionSY7
1549863IsoSol 999 MG/ML Inhalation SolutionSY7

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
ISOFLURANE Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
ac9629df-d32a-4233-ad61-63593097af8aProduct name120220516

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
50989-150-12IsoSol100 mL in 1 BOTTLE, GLASSLIQUID1007
50989-150-15IsoSol250 mL in 1 BOTTLE, GLASSLIQUID2507

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
50989-150ISOSOL (ISOFLURANE) LIQUID [VEDCO, INC.]72 package rows20230216_b69c2259-d7d8-482d-8443-6279d217da0a.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
ISOFLURANEACTIVE INGREDIENTCYS9AKD70P5
ISOFLURANEACTIVE MOIETYCYS9AKD70P5

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 2 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
50989-15050989-150-12, 50989-150-15

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 1 matching rows.

Name, UNII, Kind table
NameUNIIKind
ISOFLURANECYS9AKD70PACTIB

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 8 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
TerrellISOFLURANEPiramal Critical Care, Inc.dfb26527-c5ab-44d0-9236-24b1600e0db42026-04-13Warnings, Adverse reactionsName fallback
generic name: ISOFLURANE
Isoflurane, (Volatile for Inhalation)ISOFLURANEMullan Pharmaceutical Inc.525a2467-548d-4b10-b181-91b90e99ae1b2026-03-30Warnings, Adverse reactionsName fallback
generic name: ISOFLURANE
IsofluraneISOFLURANEShandong New Time Pharmaceutical Co., Ltd.662ceaf6-650b-4dea-bbee-652f464260242026-01-05Warnings, Adverse reactionsName fallback
generic name: ISOFLURANE
IsofluraneISOFLURANEPiramal Critical Care, Inc.13c9c37a-0c3d-450a-a61e-d2796818b18f2025-11-26Warnings, Adverse reactionsName fallback
generic name: ISOFLURANE
TerrellISOFLURANEPiramal Critical Care Incdbeb646f-dc6c-40f2-803c-68858d6ac0802025-11-06Warnings, Adverse reactionsName fallback
generic name: ISOFLURANE
IsofluraneISOFLURANEPiramal Critical Care, Inc.d6851c71-0c2f-43f6-883c-a43fe894985d2025-03-25Warnings, Adverse reactionsName fallback
generic name: ISOFLURANE
FORANEISOFLURANEBaxter Healthcare Corporation3d30eb8d-a62e-475f-926b-78ba63bee9c82024-12-09Warnings, Adverse reactionsName fallback
generic name: ISOFLURANE
IsofluraneISOFLURANEHalocarbon Life Sciences, LLCe8e57cd7-b662-4e1c-beda-e73a4b3d16ae2024-09-13Warnings, Adverse reactionsName fallback
generic name: ISOFLURANE

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.